TGFB1 and breast cancer: These mirrored the effects of LY2109761 which is a TGF‐β receptor type‐I and type‐II dual inhibitor38 (Figure 4C,D), suggesting that PFD might suppress metastasis through disturbing TGF‐β‐induced EMT in breast cancer cells.